Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 186.87

-1.9%

10:26 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (28218)	2/18/1999 9:18:00 AM
From: Henry Niman	Read Replies (2) of 32384

The breast cancer applications of course would create quite a stir. I'm fairly certain that the Phase II Breast Cancer trials are open label, so an interim report could be out by 3Q, and if the clinical data is anywhere close to the pre-clinical results, it will move the price big time. Today's press release does indicated that the insulin sensitization aspects of Targretin, identified in mouse models. was confirmed in the European Phase II trials in type II diabetes patients.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next